Pierre Legault - Net Worth and Insider Trading

Pierre Legault Net Worth

The estimated net worth of Pierre Legault is at least $705,600 dollars as of 2024-05-04. Pierre Legault is the Director of Syndax Pharmaceuticals Inc and owns about 32,000 shares of Syndax Pharmaceuticals Inc (SNDX) stock worth over $705,600. Pierre Legault is also the Director of Bicycle Therapeutics PLC and owns about 0 shares of Bicycle Therapeutics PLC (BCYC) stock worth over $0. Details can be seen in Pierre Legault's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Pierre Legault has not made any transactions after 2023-01-13 and currently still holds the listed stock(s).

Transaction Summary of Pierre Legault

Pierre Legault Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Pierre Legault owns 9 companies in total, including Urovant Sciences Ltd (UROV) , Syndax Pharmaceuticals Inc (SNDX) , and Bicycle Therapeutics PLC (BCYC) among others .

Click here to see the complete history of Pierre Legault’s form 4 insider trades.

Insider Ownership Summary of Pierre Legault

Ticker	Comapny	Transaction Date	Type of Owner
UROV	Urovant Sciences Ltd	2020-07-21	director
SNDX	Syndax Pharmaceuticals Inc	2023-01-13	director
BCYC	Bicycle Therapeutics PLC	2021-12-22	director
		2019-05-03	director
		2018-03-26	director
		2016-11-01	director
		2015-11-10	director & Chief Executive Officer
		2007-06-04	Senior EVP & CAO
		2007-03-09	director

Pierre Legault Latest Holdings Summary

Pierre Legault currently owns a total of 2 stocks. Among these stocks, Pierre Legault owns 32,000 shares of Syndax Pharmaceuticals Inc (SNDX) as of January 13, 2023, with a value of $705,600 and a weighting of 100%. Pierre Legault also owns 0 shares of Bicycle Therapeutics PLC (BCYC) as of December 22, 2021, with a value of $0 and a weighting of 0%.

Latest Holdings of Pierre Legault

Ticker	Comapny	Latest Transaction Date	Shares Owned	Current Price ($)	Current Value ($)
SNDX	Syndax Pharmaceuticals Inc	2023-01-13	32,000	22.05	705,600
BCYC	Bicycle Therapeutics PLC	2021-12-22	0	24.58	0

Holding Weightings of Pierre Legault

Pierre Legault Form 4 Trading Tracker

According to the SEC Form 4 filings, Pierre Legault has made a total of 2 transactions in Syndax Pharmaceuticals Inc (SNDX) over the past 5 years, including 0 buys and 2 sells. The most-recent trade in Syndax Pharmaceuticals Inc is the sale of 39,000 shares on January 13, 2023, which brought Pierre Legault around $1 Million.

According to the SEC Form 4 filings, Pierre Legault has made a total of 6 transactions in Bicycle Therapeutics PLC (BCYC) over the past 5 years, including 0 buys and 6 sells. The most-recent trade in Bicycle Therapeutics PLC is the sale of 150,000 shares on December 22, 2021, which brought Pierre Legault around $9 Million.

Insider Trading History of Pierre Legault

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.

Total 0

Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Pierre Legault Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Pierre Legault Ownership Network

Ownership Network List of Pierre Legault

No Data

Ownership Network Relation of Pierre Legault

Pierre Legault Owned Company Details

What does Urovant Sciences Ltd do?

Who are the key executives at Urovant Sciences Ltd?

Pierre Legault is the director of Urovant Sciences Ltd. Other key executives at Urovant Sciences Ltd include SVP & Commercial & USI Walt Johnston , CMO/Urovant Sciences & Inc. Haag-molkenteller Cornelia , and PFO;CFO/Urovant Sciences & Inc. Ajay Bansal .

Urovant Sciences Ltd (UROV) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Urovant Sciences Ltd (UROV) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Urovant Sciences Ltd (UROV) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Urovant Sciences Ltd (UROV)'s detailed insider trading history can be found in Insider Trading Tracker table.

Urovant Sciences Ltd Insider Transactions

No Available Data

What does Syndax Pharmaceuticals Inc do?

Who are the key executives at Syndax Pharmaceuticals Inc?

Pierre Legault is the director of Syndax Pharmaceuticals Inc. Other key executives at Syndax Pharmaceuticals Inc include director & Chief Executive Officer Briggs Morrison , Chief Financial Officer Keith A. Goldan , and President & Head of R&D Neil Gallagher .

Syndax Pharmaceuticals Inc (SNDX) Insider Trades Summary

Over the past 18 months, Pierre Legault made 1 insider transaction in Syndax Pharmaceuticals Inc (SNDX) with a net sale of 39,000. Other recent insider transactions involving Syndax Pharmaceuticals Inc (SNDX) include a net sale of 369,983 shares made by Briggs Morrison , a net sale of 50,069 shares made by Peter Ordentlich , and a net sale of 83,000 shares made by William Meury .

In summary, during the past 3 months, insiders sold 0 shares of Syndax Pharmaceuticals Inc (SNDX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 548,588 shares of Syndax Pharmaceuticals Inc (SNDX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 548,588 shares.

Syndax Pharmaceuticals Inc (SNDX)'s detailed insider trading history can be found in Insider Trading Tracker table.

Syndax Pharmaceuticals Inc Insider Transactions

No Available Data

What does Bicycle Therapeutics PLC do?

Who are the key executives at Bicycle Therapeutics PLC?

Pierre Legault is the director of Bicycle Therapeutics PLC. Other key executives at Bicycle Therapeutics PLC include Chief Business Officer Nigel Crockett , Chief Accounting Officer Travis Alvin Thompson , and Chief Operating Officer Alistair Milnes .

Bicycle Therapeutics PLC (BCYC) Insider Trades Summary

Over the past 18 months, Pierre Legault made no insider transaction in Bicycle Therapeutics PLC (BCYC). Other recent insider transactions involving Bicycle Therapeutics PLC (BCYC) include a net sale of 22,315 shares made by Kevin Lee , a net sale of 6,739 shares made by Alistair Milnes , and a net sale of 6,739 shares made by Michael Skynner .

In summary, during the past 3 months, insiders sold 7,222 shares of Bicycle Therapeutics PLC (BCYC) in total and bought 0 shares, with a net sale of 7,222 shares. During the past 18 months, 53,826 shares of Bicycle Therapeutics PLC (BCYC) were sold and 0 shares were bought by its insiders, resulting in a net sale of 53,826 shares.

Bicycle Therapeutics PLC (BCYC)'s detailed insider trading history can be found in Insider Trading Tracker table.

Bicycle Therapeutics PLC Insider Transactions

No Available Data

What does Adynxx Inc do?

Who are the key executives at Adynxx Inc?

Pierre Legault is the director of Adynxx Inc. Other key executives at Adynxx Inc include 10 percent owner David Bonderman , CHIEF MEDICAL OFFICER Donald C. Manning , and 10 percent owner Domain Partners Viii, L.p. .

Adynxx Inc (ADYX) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Adynxx Inc (ADYX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Adynxx Inc (ADYX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Adynxx Inc (ADYX)'s detailed insider trading history can be found in Insider Trading Tracker table.

Adynxx Inc Insider Transactions

No Available Data

What does ARMO BioSciences Inc do?

Who are the key executives at ARMO BioSciences Inc?

Pierre Legault is the director of ARMO BioSciences Inc. Other key executives at ARMO BioSciences Inc include director & 10 percent owner Orbimed Advisors Llc , 10 percent owner Orbimed Capital Gp V Llc , and 10 percent owner Orbimed Capital Gp Iv Llc .

ARMO BioSciences Inc (ARMO) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of ARMO BioSciences Inc (ARMO) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of ARMO BioSciences Inc (ARMO) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

ARMO BioSciences Inc (ARMO)'s detailed insider trading history can be found in Insider Trading Tracker table.

ARMO BioSciences Inc Insider Transactions

No Available Data

What does Regado Biosciences Inc do?

Who are the key executives at Regado Biosciences Inc?

Pierre Legault is the director of Regado Biosciences Inc. Other key executives at Regado Biosciences Inc include 10 percent owner Associates Domain , Chief Medical Officer Eric Lefebvre , and Chief Financial Officer Christopher Peetz .

Regado Biosciences Inc (RGDO) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Regado Biosciences Inc (RGDO) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Regado Biosciences Inc (RGDO) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Regado Biosciences Inc (RGDO)'s detailed insider trading history can be found in Insider Trading Tracker table.

Regado Biosciences Inc Insider Transactions

No Available Data

What does NephroGenex Inc do?

Who are the key executives at NephroGenex Inc?

Pierre Legault is the director & Chief Executive Officer of NephroGenex Inc. Other key executives at NephroGenex Inc include director & 10 percent owner Richard J Markham , 10 percent owner Joshua Ruch , and 10 percent owner Habib Kairouz .

NephroGenex Inc (NRXGQ) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of NephroGenex Inc (NRXGQ) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of NephroGenex Inc (NRXGQ) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

NephroGenex Inc (NRXGQ)'s detailed insider trading history can be found in Insider Trading Tracker table.

NephroGenex Inc Insider Transactions

No Available Data

What does Rite Aid Corp do?

Who are the key executives at Rite Aid Corp?

Pierre Legault is the Senior EVP & CAO of Rite Aid Corp. Other key executives at Rite Aid Corp include Chief Operating Officer Christopher W. Dupaul , Chief Legal Officer Sabatino Thomas J Jr , and Chief Accounting Officer Steven Bixler .

Rite Aid Corp (RADCQ) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Rite Aid Corp (RADCQ) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Rite Aid Corp (RADCQ) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Rite Aid Corp (RADCQ)'s detailed insider trading history can be found in Insider Trading Tracker table.

Rite Aid Corp Insider Transactions

No Available Data

What does Cyclacel Pharmaceuticals Inc do?

Who are the key executives at Cyclacel Pharmaceuticals Inc?

Pierre Legault is the director of Cyclacel Pharmaceuticals Inc. Other key executives at Cyclacel Pharmaceuticals Inc include director & President & C.E.O. Spiro Rombotis , director & E.V.P. & Finance & C.O.O. Paul Mcbarron , and Chief Medical Officer Mark Kirschbaum .

Cyclacel Pharmaceuticals Inc (CYCC) Insider Trades Summary

Over the past 18 months, Pierre Legault made no insider transaction in Cyclacel Pharmaceuticals Inc (CYCC). Other recent insider transactions involving Cyclacel Pharmaceuticals Inc (CYCC) include a net purchase of 6,070 shares made by Spiro Rombotis , and a net purchase of 1,886 shares made by Paul Mcbarron .

In summary, during the past 3 months, insiders sold 0 shares of Cyclacel Pharmaceuticals Inc (CYCC) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Cyclacel Pharmaceuticals Inc (CYCC) were sold and 7,956 shares were bought by its insiders, resulting in a net purchase of 7,956 shares.

Cyclacel Pharmaceuticals Inc (CYCC)'s detailed insider trading history can be found in Insider Trading Tracker table.

Cyclacel Pharmaceuticals Inc Insider Transactions

No Available Data

Pierre Legault Mailing Address

Above is the net worth, insider trading, and ownership report for Pierre Legault. You might contact Pierre Legault via mailing address: P.o. Box 1028, C/o Stone Management Llc, Berwyne Pa 19312.

Discussions on Pierre Legault

No discussions yet.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us ETF Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.